Breaking News
March 21, 2019 - Smell of skin could lead to early diagnosis for Parkinson’s
March 21, 2019 - Difference in brain connectivity may explain autism spectrum disorder
March 21, 2019 - Untangling the microbiome — with statistics
March 21, 2019 - Human microbiome metabolites enhance colon injury by enterohemorrhagic E. coli, study shows
March 21, 2019 - Written media can improve citizens’ understanding of palliative care
March 21, 2019 - New research aims to find how asthma symptoms are aggravated
March 21, 2019 - New $9.7 million NIH grant project seeks to improve hearing restoration
March 21, 2019 - Researchers measure brain metabolite levels in people with mild memory problems
March 21, 2019 - FDA approves first drug for treatment of postpartum depression in adult women
March 20, 2019 - Gene editing and designer babies experiments face global moratorium
March 20, 2019 - Major scientific study of wound care dressings wins ‘Best Clinical or Preclinical Research Award’
March 20, 2019 - Biohaven Enrolls First Patient In Phase 3 Generalized Anxiety Disorder (GAD) Trial Of Troriluzole
March 20, 2019 - Big data study identifies drugs that increase risk of psychosis in youth with ADHD
March 20, 2019 - Mystery novel and dream spur key scientific insight into heart defect | News Center
March 20, 2019 - Study measures impact of policies designed to reduce air pollution in two mega-cities
March 20, 2019 - Mild sleep apnea during pregnancy changes sugar levels and may affect infant growth patterns
March 20, 2019 - SSB and Novasep collaborate to develop new membrane chromatography systems
March 20, 2019 - Leaky valve repair improves quality of life in heart failure patients
March 20, 2019 - Diattenuation Imaging offers structural information of difficult to access brain regions
March 20, 2019 - Early sports specialization linked to increased injury rates during athletic career
March 20, 2019 - Study brings clarity about milk intake for children with Duarte galactosemia
March 20, 2019 - Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
March 20, 2019 - Maternal smoking during pregnancy increases risk of ADHD among offspring up to three-fold
March 20, 2019 - Pioneering pediatric kidney transplant surgeon Oscar Salvatierra dies at 83 | News Center
March 20, 2019 - F.D.A. Approves First Drug for Postpartum Depression
March 20, 2019 - TB remains a major public health challenge in the European region
March 20, 2019 - Most pills contain common allergens, warn experts
March 20, 2019 - Researchers discover previously unknown mechanism by which cells can sense oxygen
March 20, 2019 - World’s leading source of data on diagnosis, treatments for aortic dissection
March 20, 2019 - Breast cancer relapse predictor may soon be a reality
March 20, 2019 - Researchers identify origin of chronic pain in humans
March 20, 2019 - Two-drug combinations containing calcium channel blocker significantly lowers BP
March 20, 2019 - King’s scientists to monitor air quality exposure of 250 children
March 20, 2019 - Preventative cardioverter defibrillator implantation is of little benefit to kidney dialysis patients
March 20, 2019 - New method based on neurofeedback may reduce anxiety
March 20, 2019 - Study explores whether alcohol consumption can have an effect on arthritis
March 20, 2019 - Merck to collaborate with GenScript for plasmid and virus manufacturing in China
March 20, 2019 - FDA Approves Zulresso (brexanolone) for the Treatment of Postpartum Depression
March 20, 2019 - Study examines long-term opioid use in patients with severe osteoarthritis
March 20, 2019 - Retired Stanford professor Edward Rubenstein, pioneer in intensive care medicine, dies at 94 | News Center
March 20, 2019 - Aaron Diamond AIDS Research Center to Join Columbia University
March 20, 2019 - Call for halt to human gene editing and designer babies experiments
March 20, 2019 - Study illuminates how hot spots of genetic variation evolved in the human genome
March 20, 2019 - Roundworm study suggests alternatives for treatment of schizophrenia
March 20, 2019 - Sphingotec reports new applications of bio-ADM at 39th ISICEM
March 20, 2019 - Preventing falls through free community-based screenings for older adults
March 20, 2019 - AAOS: Supplement Use Low in Patients With Osteoporosis, Hip Fracture
March 20, 2019 - Does intensive blood pressure control reduce dementia?
March 20, 2019 - Nut consumption could be key to better cognitive health in older people
March 20, 2019 - Drinking hot tea associated with increased risk of esophageal cancer
March 20, 2019 - Androgen receptor plays vital role in regulating multiple mitochondrial processes
March 20, 2019 - NIH announces funding boost for Detroit Cardiovascular Training Program
March 20, 2019 - Study reveals another surgical option for patients with irreparable rotator cuff tears
March 20, 2019 - New robot-guided video game may be effective and low-cost solution for caregivers
March 20, 2019 - Heart Attacks Fall By One-Third Among Older Americans
March 20, 2019 - Data sharing uncovers five new risk genes for Alzheimer’s disease
March 20, 2019 - Does It Make Sense To Delay Children’s Vaccines?
March 20, 2019 - Lack of health insurance may increase Aging immigrants’ risk for cardiovascular disease
March 20, 2019 - Piece of puzzle unlocked in what drives alcohol addiction
March 20, 2019 - Researchers investigate whether Zika reservoirs are found in the Americas
March 20, 2019 - Compounds found in coffee may inhibit growth of prostate cancer
March 20, 2019 - Lab Innovations returns to the NEC on 30 & 31 October 2019
March 20, 2019 - How genes affect tobacco and alcohol use
March 20, 2019 - Osteoarthritis and rheumatoid arthritis have similar impacts on patients
March 20, 2019 - Individuals with infection history have higher risk of developing Sjögren’s syndrome
March 20, 2019 - Nursing home residents benefit from individualized multi-component exercise program
March 20, 2019 - Plant cellulose bone implants are “viable” option to support new bone growth, study finds
March 20, 2019 - Older people living in retirement communities benefit from improved health
March 20, 2019 - UTSA professor helps train first responders to detect prescription opioid overdoses
March 20, 2019 - Biohaven’s Verdiperstat Receives Orphan Drug Designation From FDA For Multiple System Atrophy
March 20, 2019 - Smoking may limit body’s ability to fight dangerous form of skin cancer
March 20, 2019 - Researchers receive $9.7-million grant to develop new hearing-loss treatments for deaf
March 20, 2019 - TGen and ABL sign agreement to distribute new TB test technology
March 20, 2019 - UCD researchers lead development of new urine test to detect prostate cancer
March 20, 2019 - Miniature brains that can move muscles, grown in the lab
March 20, 2019 - Servier and Oncodesign announce research and drug development partnership
March 20, 2019 - FDA warns marketer of unapproved products claiming to treat addiction, chronic pain
March 20, 2019 - TB Medicine Pretomanid Enters Regulatory Review Process in the United States
March 20, 2019 - Breastfeeding can erase effects of prenatal violence for newborns
March 20, 2019 - Tens of Thousands of Heart Patients May Not Need Open-Heart Surgery
Sweat shows promise for noninvasive health monitoring

Sweat shows promise for noninvasive health monitoring

image_pdfDownload PDFimage_print

Making a revolutionary biosensor takes blood, sweat and tears.

And saliva, naturally.

University of Cincinnati professor Jason Heikenfeld examined the potential of these and other biofluids to test human health with tiny, portable sensors for the journal Nature Biotechnology.

Heikenfeld develops wearable technology in his Novel Device Lab in UC’s College of Engineering and Applied Science. His lab last year created the world’s first continuous-testing device that samples sweat as effectively as blood but in a noninvasive way and over many hours.

“Ultimately, technological advances in wearables are constrained by human biology itself,” the study said.

Remarkably, many of the innovations in the field of biosensors and sweat technology were developed in Cincinnati. The first glucose monitor for diabetes was commercialized in the region. The inventor of the the world’s first antiperspirant, called Odorono, was a Cincinnati physician named Abraham Murphey.

“We have such a strong history in this field here. It’s really fascinating,” Heikenfeld said.

Heikenfeld credits the hard work of his team for his lab’s success.

“We have been able to go far and fast here,” Heikenfeld said. “We resonate with a certain type of student. As much as we have brilliant faculty at UC, if we didn’t have talented students here, this technology wouldn’t exist. We would just be talking theoretically about the potential.”

In the Nature article, Heikenfeld identified four waves of discovery when it comes to testing human health. First, doctors began drawing and shipping blood to labs in an invasive, time-consuming and labor-intensive process that patients still undergo today.

Starting around the 1980s researchers, including pioneering UC engineering professor Chong Ahn, developed point-of-care lab tests that allowed doctors to get immediate results. Instead of shipping samples to a lab, doctors could test samples themselves using tiny self-contained devices.

“Dr. Ahn has been at the forefront of developing these point-of-care devices,” Heikenfeld said.

Now, Heikenfeld said, we’re in the midst of a third wave — continuous health monitoring with wearable devices like those developed at UC. These provide data over time so doctors can track health trends instead of relying on the snapshot that a single blood test provides.

“That’s super powerful because it tells me am I getting better? Am I getting worse?” Heikenfeld said.

Eventually, the field will see devices implanted in the body for long-term diagnosis or monitoring, he said. But first researchers will have to create robust sensors that can provide accurate information over a much longer time frame.

“That’s the big challenge,” Heikenfeld said. “Sensors are chemically reactive themselves. So they don’t last.”

After examining the use of saliva, tears and interstitial fluid, Heikenfeld concluded in the Nature article that sweat holds the most promise for noninvasive testing because it provides similar information as blood and its secretion rate can be controlled and measured.

In his Novel Device Lab at UC, Heikenfeld and his students have been creating new sensors on a wearable patch the size of a Band-Aid that stimulates sweat even when a patient is cool and resting. The sensor measures specific analytes over time that doctors can use to determine how the patient is responding to a drug treatment.

The sensors can be tailored to measure anything from drugs to hormones to dehydration, Heikenfeld said.

Last year the lab created the world’s first continuous-monitoring sensor that can record the same health information in sweat that doctors for generations have examined in blood. The milestone is remarkable because the continuous sensor allows doctors to track health over time to see whether a patient is getting better or worse. And they can do so in a noninvasive way with a tiny patch applied to the skin that stimulates sweat for up to 24 hours at a time.

“This is the Holy Grail. For the first time, we can show here’s the blood data; here’s the sweat data – and they work beautifully together,” Heikenfeld said.

Heikenfeld and his students published their latest experimental findings in December in the journal Lab on a Chip. UC’s study tracked how test subjects metabolized ethanol. The study concluded that sweat provided virtually the same information as blood to measure a drug’s presence in the body.

The latest breakthrough at UC marked the culmination of more than seven years of research, he said.

“For medications, we can use sweat to get an exact measurement of concentrations in the blood,” Heikenfeld said. “That’s important because once we can measure concentrations of therapeutics in blood, we can look at drug dosing. And that could make current dosing look like something from the Stone Age.”

Cincinnati is home to several companies that are turning technologies for drug prescribing, delivery and monitoring into commercial products. The list includes Assurex Health, Enable Injections and Heikenfeld’s Eccrine Systems, where he is co-founder and chief science officer.

Study co-author and computational biologist Tongli Zhang said devices like these will help doctors to provide personalized care. Zhang is an assistant professor in the Department of Pharmacology and Systems Physiology at the UC College of Medicine.

“You don’t give children the same drug dose as adults. Likewise, we can specify a dose based on a patient’s weight,” Zhang said. “But some patients might have liver or kidney failure. And others might metabolize a drug 10 times faster. So the same dose might be ineffective in some patients and toxic in others.”

Zhang said continuous sensors could change treatments in fundamental ways.

“Personalized or individualized medicine is becoming a bigger deal. We realize it’s important. If we can understand what’s going on in the body, we can tailor the treatment accordingly,” he said.

UC is at the forefront of developing new biosensors that Heikenfeld thinks will revolutionize the way we track disease and wellness.

“UC continues to build on our rich regional history in revolutionizing diagnostics through this third wave of continuous biochemical sensing,” he said.

Source:

https://www.uc.edu/news/articles/2019/03/n2074289.html

Tagged with:

About author

Related Articles